Ginkgo Bioworks Holdings Stock Performance
| DNA Stock | USD 0.87 0.04 4.40% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Ginkgo Bioworks are completely uncorrelated. Ginkgo Bioworks Holdings has an expected return of -0.43%. Please make sure to check out Ginkgo Bioworks value at risk and the relationship between the daily balance of power and period momentum indicator , to decide if Ginkgo Bioworks Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Is Donaco International Using Too Much Debt | 03/06/2024 |
2 | Lung cancer blood tests that can speed up treatment offered to thousands of NHS patients | 03/22/2024 |
3 | Disposition of 37650 shares by Canton Barry of Ginkgo Bioworks at 1.353 subject to Rule 16b-3 | 03/28/2024 |
4 | Disposition of 1634 shares by Mark Dmytruk of Ginkgo Bioworks subject to Rule 16b-3 | 04/01/2024 |
5 | IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development Manufacturing Service | 04/08/2024 |
6 | Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across RD Value Chain | 04/10/2024 |
7 | Ginkgo Bioworks Previews Todays Annual Ferment Conference, Announces Lab Data as a Service | 04/11/2024 |
8 | Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Heres Why Thats Bullish for Both Stocks. | 04/15/2024 |
9 | Ginkgo Bioworks and Il Granaio delle Idee enter into a collaboration | 04/16/2024 |
| Begin Period Cash Flow | 1.3 B |
Ginkgo |
Ginkgo Bioworks Relative Risk vs. Return Landscape
If you would invest 123.00 in Ginkgo Bioworks Holdings on January 20, 2024 and sell it today you would lose (36.00) from holding Ginkgo Bioworks Holdings or give up 29.27% of portfolio value over 90 days. Ginkgo Bioworks Holdings is generating negative expected returns assuming volatility of 5.1358% on return distribution over 90 days investment horizon. In other words, 45% of stocks are less volatile than Ginkgo, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Ginkgo Bioworks Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ginkgo Bioworks' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ginkgo Bioworks Holdings, and traders can use it to determine the average amount a Ginkgo Bioworks' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0828
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DNA |
Estimated Market Risk
| 5.14 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ginkgo Bioworks is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ginkgo Bioworks by adding Ginkgo Bioworks to a well-diversified portfolio.
Ginkgo Bioworks Fundamentals Growth
Ginkgo Stock prices reflect investors' perceptions of the future prospects and financial health of Ginkgo Bioworks, and Ginkgo Bioworks fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ginkgo Stock performance.
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (5.16) % | ||||
| Current Valuation | 1.15 B | ||||
| Shares Outstanding | 1.65 B | ||||
| Price To Earning | 25.51 X | ||||
| Price To Book | 1.98 X | ||||
| Price To Sales | 8.65 X | ||||
| Revenue | 251.46 M | ||||
| Gross Profit | 273.49 M | ||||
| EBITDA | (600.68 M) | ||||
| Net Income | (892.87 M) | ||||
| Cash And Equivalents | 1.32 B | ||||
| Cash Per Share | 0.84 X | ||||
| Total Debt | 241.77 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 11.84 X | ||||
| Book Value Per Share | 0.55 X | ||||
| Cash Flow From Operations | (295.5 M) | ||||
| Earnings Per Share | (0.46) X | ||||
| Market Capitalization | 1.99 B | ||||
| Total Asset | 1.67 B | ||||
| Retained Earnings | (5.29 B) | ||||
| Working Capital | 837.89 M | ||||
| Current Asset | 10.07 B | ||||
| Current Liabilities | 3.1 B | ||||
About Ginkgo Bioworks Performance
To evaluate Ginkgo Bioworks Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Ginkgo Bioworks generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Ginkgo Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Ginkgo Bioworks Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Ginkgo's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.15 | 0.15 | |
| Return On Tangible Assets | (0.58) | (0.61) | |
| Return On Capital Employed | (0.45) | (0.47) | |
| Return On Assets | (0.54) | (0.56) | |
| Return On Equity | (0.81) | (0.85) |
Things to note about Ginkgo Bioworks Holdings performance evaluation
Checking the ongoing alerts about Ginkgo Bioworks for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ginkgo Bioworks Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ginkgo Bioworks generated a negative expected return over the last 90 days | |
| Ginkgo Bioworks has high historical volatility and very poor performance | |
| Ginkgo Bioworks has some characteristics of a very speculative penny stock | |
| The company reported the last year's revenue of 251.46 M. Reported Net Loss for the year was (892.87 M) with profit before taxes, overhead, and interest of 273.49 M. | |
| Ginkgo Bioworks Holdings has about 1.32 B in cash with (295.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Over 84.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from seekingalpha.com: Ginkgo Bioworks and Il Granaio delle Idee enter into a collaboration |
- Analyzing Ginkgo Bioworks' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ginkgo Bioworks' stock is overvalued or undervalued compared to its peers.
- Examining Ginkgo Bioworks' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ginkgo Bioworks' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ginkgo Bioworks' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ginkgo Bioworks' stock. These opinions can provide insight into Ginkgo Bioworks' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.